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ds. We examined the ass~ciat~om between 
he mburse of the stu 
8,080 days). 
Ventricular arrhythmias have been associated with both 
arrhythmic and nonarrhythmic death in patients discharged 
from the hospital fter myocardial infarction (1,2). Although 
the presence and frequency of such arrhythmias correlate 
weakly with left ventricular dysfunction, their prognostic 
significance for mortality is independent of left ventricular 
dysfunction (3-5). These observations have been primarily 
made in the period early after myocardial infarction. In this 
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report we examine the independent prognostic significance 
for subsequent mortality of ventricular arrhythmia r tes 
measured I year after myocardial infarction in a group of 
patients who had asymptomdtic or miioly symptomatic ven- 
tricular arrhythmias (~10 ventricular premature beats/h) 
detected between 6 and 90 days after myocardial nfarction. 
wing the Cardiac Ar- 
P S). The study protocol was ap 
proved by each of the local review boards and the National 
Institutes of Health. Each patient enrolled signed an in- 
formed consent document approved by the appropriate local 
review board and by the National Institutes of Health. 
The study group comprises the 502 postmyocardial infarc- 
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tion patients enrolled between 6 and 90 days after myocar- 
dial infarction at 10 centers for the CAPS. Details of the trial 
have been published previously (6). Briefly, patients who 
had asymptomatic or mildly symptomatic ventricular ar- 
rhythmia consisting of ~10 premature v ntricular depolar- 
ization& or r5 salvos of 3 to 9 depolarizations at arate of 
at least 100 beats/min on a 24-h ambulatory electrocardio- 
graphic (ECG) recording were eligible for enrollment. Pa- 
tients were randomly assigned to one of four active treat- 
ment arms or a placebo arm. Each patient was followed UP 
for I year with 24-h ambulatory ECGs obtained at3,6,9 and 
12 months after enrollment. At 12 months a second 24-h 
was obtained after therapy had been stopped for 
ately 1 week (median 7 days, range 3to 361). The 
study enrolled patients between July 25,1983 and August 21, 
1985; the last l-year follow-up examination was completed in 
Au 
t follow-up, In 1989 the nine U.S. clinics par- 
ticipating inthe CAPS submitted patient identification infor- 
mation to the National Death Index to ascertain vital status. 
The data included name, birth date ano social security 
number, identifying information that has previously been 
shown to provide xcellent assessment of survival (7). The 
Canadian site participating i  the CAPS conducted a sepa- 
rate manual follow-up at this time. These follow-up assess- 
ments were conducted ateach site to ensure patient confi- 
dentiality as required by the National Death Index protocol. 
In the survival analyses performed in this report we assumed 
the patients were alive or dead as of December 31, 1987 
based on information derived both from the CAPS follow- 
up, the National Death Index search and the separate 
Canadian follow-up. 
~rhythmia measurement andantiarrhythmic therapy af- 
ter the CAPS. During the year of follow-up, 56 patients were 
withdrawn from their randomized therapy and placed on 
individualized therapy that included no antiarrhythmic ed- 
ications (except a beta-receptor antagonist n some cases); 
304 patients completed the full year of follow-up on their 
assigned treatment, after which administration of their study 
drugs was stopped and not restarted, atleast immediately. 
An ambulatory ECG was obtained a median of 7 days (range 
3 to 361) after the therapy was stopped. We assume that 
most of these patients did not subsequently receive antiar- 
rhythmic medications because 1) the antiarrhythmic agents 
used for therapy in the CAPS were not yet marketed (except 
for iminramine, which was marketed but not as an antiar- 
rhythmic agent); 2) the patients and their physicians had 
Originally agreed to a placebo control; and 3) for these 360 
Patients, the decision at the end of the CXPS was to 
discontinue antiarrhythmic medication. We had no formal 
control Over treatment after the patients’ participation in the 
study, although many of the patients’ physicians were CAPS 
inves@tors. We designate he ambulatory ECG obta&$ 
for entry into the CAPS as the “early ambulatory ECG” and 
the ambulatory ECG obtained after the CAPS washout 
period as the “late ambulatory ECG.” 
Table 1. Baseline Characteristics of the Cardiac Arrhythmia Pilot 
Study Patients 
Number of patients 502 
Age (yr) 59.2 f 9.1* 
Men 83.3% 
Left ventricular ejection fraction (%) 4s + 13* 
History of 
Prior myocardial infarction 30% 
Congestive heart failure IO% 
Diabstcs mellitus 16.2% 
Use at ba.,eline of 
Beta-receptor antagonist 40.6% 
Calcium channel blocker 40% 
Diuretic agent 32.2% 
Digitalis 23.2% 
Ventricular premature depolarizations/h 151 2 24l* 
at baseline 
*Mean value + SD. 
s. Because we could not 
between arrhythmic death and ~ona~~ythmic 
death from the information obtained through the National 
Death Index, only total mortality is considered as an end 
point. The association between death and the ventricular 
premature d polarization rates is investigated byusing fail- 
ure time methodology, particularly the propo~io~ 
survival regression model of Cox (8). To examine for an 
independent association, we adjusted for a number of poten- 
tially confounding factors including left ventricular ejection 
fraction, age, gender, a history of one or more myocardial 
infarctions before the index infarction, a history of heart 
failure, a history of diabetes mellitus and use of a beta- 
receptor antagonist, calcium channel blocker, diuretic agent 
and digitalis as recorded at the time of entry to the CAPS. 
When evaluating the association of the late measure of 
ventricular arrhythmia, we included (in addition to the 
preceding factors) indications ofheart failure and of recur- 
rent myocardial infarction i  the year after the index infarc- 
tion, as well as concurrent medications at the time of the late 
ambulatory ECG. Because the distribution of the rate of 
ventricular premature depolarizations/h was strongly 
skewed to the right, a transformation with the natural log (Ln 
(ventricular p emature depolarizations/h + 1)) was made 
before analysis. 
Early ambulatory el~tr~ar~io~~m. The baseline char- 
acteristics of the 502 Cardiac Arrhythmia Pilot Study pa- 
tients are shown in Table 1. The age averaged 59 years at 
enrollment and the left ventricular ejection fraction averaged 
0.45. The average time from the index myocardial infarction 
to the early ambulatory ECG was 30 5 22 days (median 
28). There were 87 deaths during the average 1,080 C 353 
(range 3to 1,618) days of follow-up after the early ambula- 
tory ECG. 
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enl~~strat~~~ the Lack of an 
Early Measures of Ventric~Gr 
- 
Agt 
Gende. 
Ejection fraction at baseline 
History of 
Prior myocardial infarction 
Congestive heart failure 
Diabetes mellitus 
Use at baseline of 
Beta-receptor antagonist 
Calcium channel blocker 
Diuretic agent 
Digitalis 
Ventricular premature depolarizations/h 
at baseline 
Hazard Ratio* 95% c1 
1.39 (per IO yr f ) 1 .OS-r .s4 
NA 
1.37 (per 0.10 1 ) 1.12-1.68 
1.47 (yes/no) 0.93-2.30 
NA 
I .85 (yes/co) 1.13-2.91 
0.61 (yes/no) 0.36-l .06 
I .88 (yes/no) 1.19-2.97 
E .8! (yes/no) 1.13-2.9s 
NA 
NA 
*Hazard (instantaneous probability of death) ratio based on the multivari- 
ate model adjusted for the other covariates. CI = confidence interval; NA = 
no association found tp > 0. I). 
The results of the failure time analysis for the data 
obtained at entry into the CAPS are shown in Table 2. 
Complete data were available for 493 of the 502 patients, 83 
of whom died. Mortality was associated with advanced age, 
a lower e.jeclion fraction, one or more my0cardia.l nfarctions 
before the index infarction, a history of diabetes mellitus and 
concurrent use of a calcium channel blocker or a diuretic 
agent and the absence ofbeta-receptor antagonist treatment. 
It was not associated with gender, ahistory of heart failure, 
digitalis use or, as would be expected for the truncated 
sample (that is, patients elected from those in the upper 
quintile of ventricular p emature d polarization frequency), 
the measure ofventricular rhythmia r te. 
bolatory ECG. Of the 5Q2 patients, 410 had a 24-h 
ambulatory ECG obtained while they were not receiving 
antiarrhythmic medications, and 50 of these were immedi- 
ately returned to active antiarrhythmic therapy by their 
private physician. For the 360 who remained without anti- 
arrhythmic drugs, the average time from the index myocar- 
dial infarction to the late ambulatory ECG was 397 days: all 
but 12 ECGs were obtained at 2360 days. The rank corre- 
lation between the early and late rates of ventricular p ema- 
ture depolarization was 0.243. Baseline characteristics of 
these 360 patients demonstrate a slightly lower risk profile 
than that of the other 142 patients (TabFe 3). During the 
l-year of follow-up and before the late ambulatory ECG, 
31.4% had at least one episode of new or worsened heart 
failure and 5.6% had a recurrent myocardial infarction. 
Table 4 shows the characteristics of these 360 patients 
further subdivided into subgroups with a low (<3), medium 
(23 and <IO) or high (~10) rate of ventricular premature 
depolarizations/h as measured on the late ambulatory ECG. 
Most variables (exceptions are gender and diabetes mellitus) 
are associated with these subgroupings: left ventricular 
T&k 3. B isehnt Characteristics of Patients With Versu: 
j :rose &n out a 24-Hour KG Recording I Year After 
With Without 
in = 360) (n = 142) p Value - 
Age !yr) 59.0 Z 9.4* 59.6 ?r 8.5* NS 
Men 84.2% 81% NS 
LV ejeclion fraction 0.46 s O.13* 0.42 f 0.13” Q.01 
History of 
Myocardial infarction 28. I% 35% NS 
Congestive heart failure 8.1% 15.3% 0.02 
Diabetes me\lilus 14.4% 20.7% NS 
Use at baseline of 
Beta-receptor antagonist 45.3% 28.6% 0.001 
Calcium channel-blocker 3R 6% 43.6% NS 
Diuretic agent 27.8% 43.6% 0.001 
Digitalis 20.84 29.3% 0.05 
Ventricular premature !a? 2 224* I93 + 278’ NS 
depolarizalionslh at baseline 
*Mean + SD. ECG electrocardiogram; 6-V = left ventricular. 
~j~~~~~rn fraction and beta-receptor antagonist use are asso- 
ciated inversely with ventricular premature d polarization 
rates. In contrast, increasing age, myocardial infarction 
before the index infarction, heart failure before ntry into the 
S, use of a diuretic drug, digitalis or calcium channel 
blocker, ecent heart failure and recurrent myocardial nfarc- 
. Characteristics of Patients Grouped According to 
Ventricular Premature Depolarization (VPD! Freqcency Measured 
Without Antiarrhythmic Therapy and 2 1 Year After Myocardial 
Infarction (mean 397 + 41 days) 
23 VPDlh 
and 
c3 VPDih <IO VPD/h =I0 VPDih 
in = 70) (n = 65) (n = 225) 
Age W 56.6 59.6 60.2 
Male 81.4% 83.1% 85.3% 
Ejection fraction at baselix 0.49 3.48 0.44 
History at baseline of 
Prior myocardia! infarction 11.4% 16.9% 36.4% 
Congestive heart failure 4.3% 6.2% 9.9% 
Diabetes mellhus 8.6% 20.0% 14.9% 
Use at baseline of 
Beta-receptor antagonist 55.7% 55.4% 39.1% 
Calcium channel-blocker 32.9% 33.9% 41.8% 
Diuretic agent 21.4% 21.5% 31.6% 
Digitalis 19.1% 18.5% 22.7% 
Use at time of late arrhythmia measure 
Beta-receptor antagonist 45.6% 49.2% 35.8% 
Calcium channel-blocker 32.4% 33.3% 41.2% 
Diuretic agent 29.49 31.7% 49.6% 
Digitalis 17.6% 22.2% 28.8% 
Recent congestive heart failxe 22.9% 24.6% 36.0% 
Recent myocardial infarction 0% 4.6% 9.6% 
Average time of follow-up after i-yr 830 786 961 
Holter KG tdavs) 
Death after I-y; Holier ECG 4.3% 6.2% IS.I% 
Abbreviation as in Table 3. 
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Table 5. Stepwise Survival Regression Analysis for the 
Inderrendent Association of Late Measures of Ventricular 
Arrhythmia and Subsequent Mortality 
Hazard Ratio* 95% CI 
History of diabetes mellitus 
Use at baseline of 
Calcium channel blocker 
Diuretic agents 
Recent congestive heart failure 
Venlricular premature 
depolarizations/h 
2.28 (yes/no) 1.16-4.49 
1.72 (yes/no) 0.91-3.24 
2.01 (yes/no) I .07-3.78 
2. I1 (yes/no) 1.06-4.21 
1.56 (3-fold increaselt 1.2~1.95 
*Hazard (instantaneous probability of death) ratio from multivariate 
model adjusted for the other covariates. tA threefold increase in rate, such as 
fram 3 to 9 ventricular prcmaturc depolarizations/h. Thus, the hozard for the 
group with the high rate (zltllhl is >1,56 times as great as the hazard for the 
group with the low rate (<3/h). Abbreviation as in Table 2. 
tion are positively associated with ventricular premature 
depolarization rates. Complete data were not available for 
four patients, In the remaining 356 patients there were 41 
deaths during an average of779 (range 7to 1,240) days of 
follow-up after the ambulatory ECG at 1 year was obtained. 
The reablts of the multivariate stepwise failure time 
analysis for the ambulatory ECGs obtained after 1 year in 
the study are shown in Table 5. Variables demonstrating a 
significant i dependent association with mortality included a
history of diabetes mellitus, baseline use of a diuretic or 
calcium channel blocker, a recent episode of heart failure 
and, most significantly, the arrhythmia r te (p < 0.001). 
Role of the screening process for CAPS. In our study 
group, the ventricular rhythmia Irate measured arly after 
myocardial infarction was not predictive of subsequent 
mortality (p = 0.071, whereas the arrhythmia r te approxi- 
mately 1 year after infarction was strongly predictive of 
subsequent mortality (a < 0.001). The former result is 
expected because the CAPS patients were highly selected; 
that is, al! patients were required to be in the top quintile of 
the ventricular p emature d polarization frequency distribu- 
tion. The screening criteria of 210 ventricular p emature 
depolarizations& placed these patients on the upper flat 
portion of the S-shaped curve relating mortality and ventric- 
ular premature depolarization rates as described by Bigger 
(9). Other groups tudied have had a broad range of ventric- 
ular premature d polarization frequency from no arrhythmia 
to symptomatic arrhythmia, and the most striking contrasts 
have been between those patients with almost no ventricular 
arrhythmia (~3 ventricular p emature d polarizations/h) and 
those with 23 ventricular p emature depolarization& (3). 
Also, 74% of the CAPS patients were receiving antiarrhyth- 
mic medication during most of the 1st year after myocardial 
infarction. Another possible factor is that patients were 
enrolled in the CAPS on the basis of a screening ambulatory 
ECG; therefore the patients at the lower end of the arrhyth- 
*YZ_C :.:+=_T_z_-_ syy_~--_~-------------L--- ______. 
~_..._..-_...._...-...-___ _.._... _ . . . . 
_! go 
a loor > 80 2 70 p = 0.0143 
- HIGH ._.._ .-.-- MED,“M 
------ LOW 
‘b:o 1.0 2.0 
YEAR 
Figure 1. Kaplan-Meier estimates of survival in patients with Bow, 
medium and high rates of ventricular premature depolarizations 
measured 1 year after myocardial infarction. igh = 2 10 ventricular 
premature depolarizations/h (n = 225); medium = 23 and <lo 
ventricular premature depolarizations/h (n = 65); low = <3 ventric- 
ular premature depolarizations/h (n = 70). Note that 0 time in the 
graph corresponds to approximately I year after myocardial infarc- 
tion. 
mia frequency spectrum ay have baseline values that end 
to be exaggerated compared with usual evels. Thus, the 
screening process leads so measurement rror and conse- 
quently to lower power to detect an association. 
Finally, a number of investigators (10-13) have noted that 
there is extreme variability from hour to hour, day to day 
and week to week in measured ventricular rhythmia r tes 
in the early postmyocardia! infarction period. Thus, in the 
early ~~~t~nfarctio~ phase the arrhythmia rate might be 
considered a “soft” measure ofthe underlying dysfunctional 
structure and hence not predictive ina very homogeneous 
group because the variation due to error would be relatively 
large compared with the variation within the group. It might 
also be argued that he arrhythmia r te observed early after 
infarction should be more strongly associated with Is&year 
mortality rather than mortality after the 1st year. We exam- 
ined tills by conducting a failure time analysis, restricted to
the 1st year of follow-up. We did not find any univariate or
multivariate independent association f the early measured 
ventricular rhythmia r te and Is&year mortality. 
!L& postinfar&ioa arrhy 
strong associa.tion observed between arrhythmia measured 1 
year :after r yocardial infarction and subsequent mortality is
new and important information. This relation was observed 
in a patient group that had significant arrhythmia levels oon 
after myocardial infarction. (The Coronary Drug Project 
Research Group [141 reported an association between mor- 
tality and the observation f ventricular p emature d polar- 
izations on a rest ECG obtained r3 months after myocardial 
infarction.) Over a reasonable range of arrhythmia r tes the 
association is of such a nature that every threefold increase 
in the arrhythmia r te corresponds to an approximate 50% 
increase in the risk of a fatal event. This is displayed 
graphically in Figure 1, in which estimates of survival are 
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eaths 
LVEF i%) 
<40 112 I7 15.2 
VPDlb 
=10 80 17 21.3 
<lo 32 0 0 
240 248 24 9.1 
2;” 145 17 11.7 
<lo 103 7 6.8 
LVEF = left ventricular ejection fraction; VPD = ventricular pre,nature 
depolarization. 
his association exists even after adj~st~~~ for left ven- 
tricular ejection fraction (Table ), a Maddox similar to that 
reported for a~kytkm~as obser 
levels of arrhythmia freq~eocy may be 
in conjunction with more pronounced left ven 
nce (21.3% vs. O%, Table 6) is signifi- 
ever, in a survival nalysis restricte 
us) variables the interaction was 
interaction has n 
We also found a strong association between mortal- 
ity and the presence of salvos of vent&u 
depolarizations detected i year after myoca 
after adjusting for other covariates (the relati 
and 1.7, respectively, when the data were and were not 
adjusted for ventricular p emature d polarizations). Several 
large studies (3,16) have shown ventricular p emature d po- 
larization frequency and runs of premature ventricular de- 
polari7atioss to have independent significance. However, 
because the probability of observing such runs is strikingly 
associated with the number of ambulatory EC& obtained 
(l?), we believe that the ra:e of ventricular premature 
depolarization is the better measure ofrisk. 
ns. Several limitations apply to our study of the 
ass between ventricular premature depolarizations 
1 year after myocardia! infarction and subsequent mortality. 
The most important of these is that we do not know 
for certain that these patients were not receiving anti- 
arrhythmic therapy during tke interval from the late ambu- 
latory ECC to the end of the study. Althougk it is possible 
that most of them were not, it is also possible tkat any who 
were, were more likely to be among those with higher 
rates of ventricular p emature d polarization. those drugs 
were encainide or flecainide (which were not marketed or 
widely available at the end of the Cardiac Arrhythmia Pilot 
Study), we have strong evidence (18) that hey increased the 
observed. 
s. The lack of an observ relation between 
nfarction measure ofarrh 
is expected because ofpatient selection; however, the strong 
observed relation between late measured arrkyth 
cially in view of the tmncate 
xploration. Is it pos 
ere at exceptionally kig 
cardiovascular mortality other causes, suck as heart 
failure, leaving those at om their ventricular rkyth- 
mias more “exposed”? e observed relation is~pke~d, it 
would suggest the need for studies to evaluate long-term 
treatment after myocardial infarction. 
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